Evidence that juvenile myelomonocytic leukemia can arise from a pluripotential stem cell

Blood. 2000 Sep 15;96(6):2310-3.

Abstract

Children with neurofibromatosis type 1 (NF1) carry germline mutations in one allele of the NF1 gene and are predisposed to myeloid malignancies, particularly juvenile myelomonocytic leukemia (JMML). Disruption of the remaining NF1 allele can be found in malignant cells. Flow cytometric cell sorting techniques to isolate the malignant cell populations and molecular genetic methods to assay for somatic loss of the normal NF1 allele were used to study an unusual child with NF1 and JMML who subsequently had T-cell lymphoma. The data show that malignant JMML and lymphoma cells share a common loss of genetic material involving the normal NF1 gene and approximately 50 Mb of flanking sequence, suggesting that the abnormal T-lymphoid and myeloid populations were derived from a common precursor cell. These data support the hypothesis that JMML can arise in a pluripotent hematopoietic cell.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Differentiation
  • Child, Preschool
  • Dosage Compensation, Genetic
  • Humans
  • Leukemia, Myelomonocytic, Acute / etiology*
  • Leukemia, Myelomonocytic, Acute / genetics*
  • Leukemia, Myelomonocytic, Acute / pathology
  • Lymphoma, T-Cell / etiology*
  • Lymphoma, T-Cell / genetics*
  • Lymphoma, T-Cell / pathology
  • Male
  • Neoplasms, Second Primary
  • Neoplastic Stem Cells / pathology*
  • Nerve Tissue Proteins / genetics*
  • Neurofibromin 1

Substances

  • Nerve Tissue Proteins
  • Neurofibromin 1